Patents/Assignees

Loxo Oncology, Inc.

8 patents in portfolio

US12551463utility2026
Dosing of a Bruton's Tyrosine Kinase Inhibitor
0 cites
US12268666utility2025
Spray-dried Dispersions, Formulations, and Polymorphs of (s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1h-pyrazole-4-carboxamide
0 cites
US12220401utility2025
Compounds Useful as Kinase Inhibitors
0 cites
US12138250utility2024
Formulations of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile
0 cites
US12109193utility2024
Spray-dried Dispersions, Formulations, and Polymorphs of (s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1h-pyrazole-4-carboxamide
0 cites
US12102621utility2024
Formulations of 6-(2-hydroxy-methylpropoxy-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile
0 cites
US11963950utility2024
Formulations of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile
0 cites
US11826351utility2023
Compounds Useful as Kinase Inhibitors
0 cites